Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Placabo

PreclinicalSmall molecule

AAllergopharma GmbH & Co. KG

1

Indications

6

Total Trials

3

Active Trials

0

Competitors

Timeline

Expected Milestones

Q4 2027

Phase 2Not yet recruiting

Parkinson Disease (PD)

NCT07903038

Q2 2029

ApprovedNot yet recruiting

Morbid Obesity

NCT07859150

Clinical

Trials by Indication[1]

Conjunctivitis1 trial

2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma

Completed·AAllergopharma GmbH & Co. KG·Phase 3·NCT01353755·195 enrolled

Acute bronchitis1 trial

To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis

Completed·KKorea Arlico Pharm. Co., Ltd·Phase 2·NCT07061925·169 enrolled

Sedation1 trial

Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)

Not yet recruiting·OOman Medical Speciality Board·N/A·NCT07166666·128 enrolled

Parkinson Disease (PD)1 trial

Effect of Lemborexant on Perioperative Sleep Quality in Patients With Parkinson's Disease Undergoing Deep Brain Stimulation: A Randomized, Double-blinded, Placebo-controlled Clinical Trial

Not yet recruiting·BBeijing Tiantan Hospital·Phase 2·NCT07903038·128 enrolled

Morbid Obesity1 trial

Semaglutide 2.4 mg Once Weekly for Recurrent Weight Gain After Metabolic and Bariatric Surgery (RESURGE): a Randomized, Double-Blind, Placebo-Controlled Trial

Not yet recruiting·GGeneral Committee of Teaching Hospitals and Institutes, Egypt·Approved·NCT07859150·104 enrolled

1 more indication

Erectile Dysfunction1 trial

Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men With Erectile Dysfunction: A Randomized, Double-Blind, Bi-centric, Placebo- and Sham-Controlled Trial

Completed·MMenoufia University·Approved·NCT07574268·185 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Placabo. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Placabo compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Placabo. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Allergopharma GmbH & Co. KG company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AAllergopharma GmbH & Co. KG

Related News